SCHEMBL7977029

SCHEMBL7977029

CC1C(c2ccccc2)OCCN1C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ POLB P06746 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ SLC6A2 P23975 5/20 0.41
▸ SLC6A3 Q01959 5/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ CYP2C19 P33261 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.39
▸ SLC6A4 P31645 4/20 0.38
▸ CYP2D6 P10635 4/20 0.38
▸ TSHR P16473 3/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7977026 0.85 HTR1A (0.58) HTR1AL3MBTL1POLBSMN1; SMN2SLC6A2
SCHEMBL11767375 0.79 HTR1A (0.48) HTR1AL3MBTL1POLBSMN1; SMN2SLC6A2
SCHEMBL2599526 0.76 HTR1A (0.67) HTR1ASMN1; SMN2SLC6A2SLC6A3HTR2B
Phendimetrazine SCHEMBL2325477 0.75 HTR1A (0.75) HTR1AL3MBTL1POLBSMN1; SMN2SLC6A2
Phendimetrazine SCHEMBL15064942 0.74 HTR1A (1.00) HTR1ASMN1; SMN2SLC6A2SLC6A3HTR2B
Phendimetrazine SCHEMBL344020 0.74 HTR1A (1.00) HTR1ASMN1; SMN2SLC6A2SLC6A3HTR2B
Phendimetrazine SCHEMBL598950 0.74 HTR1A (1.00) HTR1ASMN1; SMN2SLC6A2SLC6A3HTR2B
Phendimetrazine SCHEMBL49481 0.74 HTR1A (1.00) HTR1ASMN1; SMN2SLC6A2SLC6A3HTR2B
SCHEMBL4613765 0.73 RIPK1 (0.48) L3MBTL1POLBSIGMAR1RIPK1
Phendimetrazine SCHEMBL160376 0.72 HTR1A (0.75) HTR1AL3MBTL1POLBSMN1; SMN2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 — — WO disclosed
Send feedback